Login    Join free Add to favorites    中文
home > news > The 8th Annual Generic International Asia Summit 2018
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
The 8th Annual Generic International Asia Summit 2018

hits:1018     Date:01/04/18

The 8th Annual Generic International Asia Summit 2018

April 19-20, 2018 鈭 New Century International Hotel, Shanghai China
Co-Organizer: China State Institute of Pharmaceutical Industry⼁Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Supporter: Menet | Shanghai Pharma|DCB
Dear colleagues,
First thanks you trust and support on GIS Asia 2017.Under your support, it became a great success. Over350 industrial leaders attended the conference and more than 90% participants are highly satisfied with the summit. This is a great encouragement inspires us to work hard and do better.
For GIS Asia 2018, in order to make the first class agenda, we invited Dr.Jack Aurora as our consultant. Many industrial leaders gave us very valuable suggestions and supports. Doing all those things with only one purpose, we long to provide you the best platform for learning and communication and live up to your support and trust. Two day鈥檚 conference almost covers all the hot topics and key issues in the generic field. We also invited the first class experts from China and Oversea Countries to share their valuable insights and experience on strategy, technology and regulatory. I believe you who have a good eye for conference selection will find our uniqueness.
The 4 dedicated streams will focus on:
♦ Formulation Design and development
♦ Analytical Development and Support
♦ Regulatory Planning and Clinical Trials
You鈥檒l also discover innovation and breakthroughs at all levels of GENERIC development. From big pharma, through the smaller companies all the way to university research teams and spin outs.We expect over 500 senior industrial leaders attending the conference.
GIS 2018 Part of Confirmed Speakers
  • Suveer Shrivastava,Vice President - Quality ,Mylan Laboratories Limited        
  • Hong Chen,VP,R&D, Yiling Pharmaceutical
  • Mufeng  Xie,Researcher,Shanghai Institute for Food and Drug Control
  • Fuyao Zhang,President,Shanghai Selection Bioscience Co.Ltd
  • Baiming Xiao,Consultant ,Simcere Pharmaceutical
  • Fred Xi,SVP, Overseas Pharmaceuticals
  • Rongye Chen, professor, many domestic enterprises technical advisors
  • Wenjun Tang,Research Professor,Shanghai Institute of Organic Chemistry
  • Venkateswarlu Vobalaboina, Managing Director, Neuheit Pharma Technologies
  • Xiaohua Zhang,Principal Scientist, Merck
  • Goutam Muhuri,President, R&D Formulation, Ipca Laboratories.
  • Xiaodi Guo,CSO,Huahai US
  • Yazhou Sun,VP,Beijing Ruiye Pharmaceutical Co.,Ltd
  • Jianying Wang,Vice President of Regulatory Affairs,Anbison Laboratory
  • Guobin Ren,Vice Dean,School of Pharmacy ,East China University of Science and Technology
  • Xiaobin Shen,Senior CMC Reviewer,FDA
  • Henry Sun,VP Research,Tianjin Tasly Group
  • Eric Sun,Former VP of Drug Research Institute,Yangtze River PharmaceuticalGroup
  • Hongchun Qiu,VP,Prinbury Biopharm
  • Sherry Ku,CEO, Savior Lifetec Co., Ltd.
Contact: Luke Xia,
T:+86-21-6053 89627
F: +86-21-6537 7300
Related News>> more

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙